Assessed by the HAMD depression scale, respectively, before treatment and after treatment 1, 2, 3, 4 weeks assessed.
经hamd量表评定抑郁状态，分别于治疗前及治疗后第1、2、3、4周进行评定。
Methods the patients were randomly assigned into venlafaxine and maprotiline group and tested with HAMD, HAMA and TESS at the time of weeks 1, 2, 4, 6 weeks after treatment.
方法采用随机对照方法，以马普替林为对照组，应用HAMD、HAMA、TESS量表，在疗前、疗后1、2、4、6周进行疗效及副反应评定。
Objective To explore the validity and reliability of the 6-item Hamilton Depression Rating Scale (HAMD-6).
目的检验汉密顿抑郁量表6项版本（HAMD-6）的信度与效度。
There were significantly positive correlation in the level of ACTH and the scores of HAMD in PSD group before treatment, also in PSD group with or without antidepressant treatment after treatment.
在治疗前PS D组及在治疗后的PS D抗抑郁治疗组和PSD无抗抑郁治疗组中，HAMD评分与血清acth水平呈显著性正相关。
Results: The results of ITAQ were consistent with clinical standard, while significantly different with HAMD.
结果：ITAQ与临床标准评定结果一致，与HAMD评定结果差异显著。
Hamilton depression rating scale (HAMD) was used to evaluate the severity of depression.
采用汉密尔顿抑郁量表(HAMD)评定抑郁的严重程度。
Changes of scores for Hamilton Depression Rating Scale (HAMD) and Pittsburgh Sleep Quality Index (PSQI) were investigated in the two groups.
观察两组汉密尔顿(HAMD)量表及匹兹堡睡眠质量指数(PSQI)量表治疗前后的变化情况。
Method HAMD depression measuring scale tests were performed for the clinical symptom characteristics in patients with depressive neurosis according to CCMD - 2 - r.
方法对符合CCMD-2 - R的抑郁性神经症患者进行HAMD抑郁量表检测，找出临床症状特征。
The patients had been regularly tested by the Hamilton Depression Rating Scale for Depression(HAMD), the lesion location was analyzed by MRI.
所有患者均常规行汉密尔顿抑郁量表（HAMD）评分，根据头颅MRI结果分析病变部位。
Results: The score of Y-BOCS, HAMD, HAMA in obsessive-compulsive disorder group was higher than that in schizophrenia group with obsessive-compulsive symptoms(P<0.01).
结果：强迫症组的Y-BOCS、HAMD、HAMA等总分明显高于伴强迫症状的精神分裂症组（P<0.01）； 治疗后各量表总分明显下降（P<0.01）。
The state of depression was measured with Hamilton rating scale for depression (HAMD) and serum BDNF levels in depression patients and healthy controls were assayed by ELISA.
采用汉密尔顿抑郁量表(HAMD)评定患者组及对照组的抑郁状态；采用ELISA检测各组血清bdnf水平。
All patients were evaluated by Hamilton Depression scale (HAMD) and Functional Comprehensive Assessment scale (FCA) before and after the treatment.
治疗前后评定用汉密尔顿抑郁量表(HAMD)和功能综合评定量表(FCA)。
Significant differences were also found in the factor analysis of HAMD scores, illness behaviour, course of illness, age of onset and family history.
两组在HAMD因子分析、疾病行为与态度、病程演变及发病背景方面存在显著差异。
Method The Coping Styles Questionnaire and Hamilton Depression Scale (HAMD) were used in 78 patients with depression pretreatment and post treatment and 86 healthy control.
方法采用应付方式问卷，评定78例抑郁症患者治疗前、后应付方式的改变，并与86例正常对照比较，用HAMD评定疾病的严重程度和疗效。
There was a positive correlation between the diminution of HAMD scores and the serum estradiol levels before treatment.
HA撇分数与血清孕酮和翠酮水平均无相关性。
Methods 30 depression patients were treated with citalopram and other 30 patients with armitpriptyline. The effect and side effects were assessed with HAMD and TESS, and the cost was contrasted.
方法采用HA MD和TESS，对30例服用西酞普兰和30例服用阿米替林的抑郁症患者的疗效和副反应进行比较，并对其费用进行比较分析。
The therapeutic effect was evaluated by HAMD periodically.
采用汉密尔顿抑郁量表(HAMD)定期进行疗效评定。
Results Study group at the 4th weekend, CGI and HAMD scores were significantly lower than the same period in the control group, two groups had significant difference(P<0.05).
结果研究组在第4周末CG I及HAMD评分均显著低于同期对照组，两组比较差异有统计学意义（P〈0.05）。
Methods The clinical symptoms and therapeutic effects were assessed with HAMD scales, and then evaluate the correlation of activities of daily living and depression complicated by stroke.
方法采用汉密尔顿抑郁量表进行抑郁症状评定和临床疗效比较分析，进一步分析日常生活依赖程度及并发抑郁的相关性。
Methods it was estimated for Hamilton Depressive Rating Scale (HAMD) and the parameters of Sleep EEG in 18 patients with depression and 10 normal controls.
方法对18例抑郁症和10例正常人评定汉密尔顿抑郁评定量表(HAMD)和检测睡眠脑电图。
Results: After treatment, HAMD scale score compared with the control group was statistically significant (P0.05).
结果：治疗后治疗组hamd量表评分与对照组比较差异有统计学意义(P 0.05)。
After treatment, the scores assessed by HAMD was lower than those before treatment (P0.05).
忘忧汤与百优解治疗后hamd分数明显低于治疗前(P 0.05)。
HAMD and TESS were used to assess the efficacy and side effects before the treatment and 1st week, 2nd week, 4th week and 6th week after it.
疗程6周，采用汉密尔顿抑郁量表(HAMD)和副反应量表(tess)法，在治疗前，治疗后第1,2,4,6周，分别评定药物疗效和不良反应。
The efficacy was evaluated by HAMD scales.
采用汉密尔顿抑郁量表(HAMD)进行疗效评定。
HAMD scores were compared before and after treatment were significantly different, between the two groups showed no significant difference.
治疗前后HAMD评分比较两组均有显著性差异，两组间则无显著性差异。
Objective to discuss the different factorial structure of HAMD Scale between the patients of liver Qi stagnation syndrome and liver stagnation and spleen deficiency syndrome.
目的探讨中医辨证为肝郁气滞型与肝郁脾虚型抑郁症患者在HAMD抑郁量表结构因素方面的差异。
Conclusion Depression patients with different syndromes have significant differences in factorical structure, though they may have the same HAMD scores, so individualized treatment is more suitable.
结论抑郁症患者虽然HAMD量表得分相同，但是其症状构成差异较大，更适合个体化的治疗。
Conclusion Depression patients with different syndromes have significant differences in factorical structure, though they may have the same HAMD scores, so individualized treatment is more suitable.
结论抑郁症患者虽然HAMD量表得分相同，但是其症状构成差异较大，更适合个体化的治疗。
应用推荐